{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:35:33Z","timestamp":1774416933082,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":5550,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.jpain.2008.02.002","type":"journal-article","created":{"date-parts":[[2008,4,4]],"date-time":"2008-04-04T12:44:11Z","timestamp":1207313051000},"page":"639-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Intrathecal Rosiglitazone Acts at Peroxisome Proliferator\u2013Activated Receptor-\u03b3 to Rapidly Inhibit Neuropathic Pain in Rats"],"prefix":"10.1016","volume":"9","author":[{"given":"Sajay B.","family":"Churi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar S.","family":"Abdel-Aleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiranjeet K.","family":"Tumber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Scuderi-Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley K.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2008.02.002_bib1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cardiores.2004.12.008","article-title":"Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock","volume":"65","author":"Abdelrahman","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jpain.2008.02.002_bib2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tips.2005.03.003","article-title":"PPAR-s: Therapeutic targets for metabolic disease","volume":"26","author":"Berger","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jpain.2008.02.002_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/138161206780574579","article-title":"PPAR-gamma agonists as regulators of microglial activation and brain inflammation","volume":"12","author":"Bernardo","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jpain.2008.02.002_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.bjp.0703628","article-title":"Bisphenol A diglycidyl ether (BADGE) is a PPAR-gamma agonist in an ECV304 cell line","volume":"131","author":"Bishop-Bailey","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2008.02.002_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jpain.2008.02.002_bib6","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1046\/j.1471-4159.1998.70041366.x","article-title":"Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system","volume":"70","author":"Cullingford","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.jpain.2008.02.002_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(00)00276-1","article-title":"Spared nerve injury: An animal model of persistent peripheral neuropathic pain","volume":"87","author":"Decosterd","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2008.02.002_bib8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation","volume":"88","author":"Dehmer","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.jpain.2008.02.002_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1073858403259950","article-title":"Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance\/hyperalgesia","volume":"10","author":"DeLeo","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jpain.2008.02.002_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1042\/bj3620573","article-title":"Bisphenol A diglycidyl ether induces apoptosis in tumour cells independently of peroxisome proliferator-activated receptor-gamma, in caspase-dependent and -independent manners","volume":"362","author":"Fehlberg","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.jpain.2008.02.002_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1124\/mol.105.012260","article-title":"Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling","volume":"68","author":"Gardner","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jpain.2008.02.002_bib12","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2008.02.002_bib13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/1531-8249(20010201)49:2<276::AID-ANA53>3.0.CO;2-5","article-title":"Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease","volume":"49","author":"Heneka","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpain.2008.02.002_bib14","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/awh452","article-title":"Acute treatment with the PPAR-gamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice","volume":"128","author":"Heneka","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jpain.2008.02.002_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2004.07.012","article-title":"An overview on biological mechanisms of PPARs","volume":"51","author":"Kota","year":"2005","journal-title":"Pharm Res"},{"key":"10.1016\/j.jpain.2008.02.002_bib16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cell.2005.11.026","article-title":"The many faces of PPAR-gamma","volume":"123","author":"Lehrke","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jpain.2008.02.002_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1152\/physrev.00003.2003","article-title":"Nongenomic steroid action: controversies, questions, and answers","volume":"83","author":"Losel","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jpain.2008.02.002_bib18","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/jpet.106.111385","article-title":"Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha","volume":"319","author":"LoVerme","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2008.02.002_bib19","first-page":"109","article-title":"Intrathecal catheterization and drug delivery in the rat","volume":"99","author":"Malkmus","year":"2004","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.jpain.2008.02.002_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1700","article-title":"Role of the immune system in chronic pain","volume":"6","author":"Marchand","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jpain.2008.02.002_bib21","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2165\/00003495-200262100-00004","article-title":"Metabolic and additional vascular effects of thiazolidinediones","volume":"62","author":"Martens","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.jpain.2008.02.002_bib22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI27958","article-title":"Involvement of PPAR-nuclear receptors in tissue injury and wound repair","volume":"116","author":"Michalik","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpain.2008.02.002_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainresrev.2005.11.004","article-title":"Immune and inflammatory mechanisms in neuropathic pain","volume":"51","author":"Moalem","year":"2006","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.jpain.2008.02.002_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","article-title":"Peroxisome proliferator-activated receptors and inflammation","volume":"110","author":"Moraes","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jpain.2008.02.002_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS","volume":"123","author":"Moreno","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2008.02.002_bib26","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.106.113472","article-title":"Thiazolidinedione class of peroxisome proliferator-activated receptor (gamma) agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats","volume":"320","author":"Miranpuri","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2008.02.002_bib27","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.jpain.2008.02.002_bib28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0306-4522(99)00417-0","article-title":"Studies of cerebrospinal fluid flow and penetration into brain following lateral ventricle and cisterna magna injections of the tracer [14C]inulin in rat","volume":"95","author":"Proescholdt","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2008.02.002_bib29","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1523\/JNEUROSCI.2038-05.2005","article-title":"The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice","volume":"25","author":"Schutz","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2008.02.002_bib30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.bbrc.2005.09.085","article-title":"Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPAR-gamma","volume":"337","author":"Soares","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jpain.2008.02.002_bib31","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","article-title":"Therapeutic roles of peroxisome proliferator-activated receptor agonists","volume":"54","author":"Staels","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jpain.2008.02.002_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuint.2006.03.020","article-title":"PPAR-gamma as a therapeutic target in central nervous system diseases","volume":"49","author":"Sundararajan","year":"2006","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jpain.2008.02.002_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0304-3959(01)00481-X","article-title":"Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors","volume":"96","author":"Taiwo","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2008.02.002_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsbmb.2004.12.025","article-title":"Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes","volume":"93","author":"Tan","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jpain.2008.02.002_bib35","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0022-3565(25)38602-7","article-title":"A unique central cholinergic deficit in the spontaneously hypertensive rat: Physostigmine reveals a bradycardia associated with sensory stimulation","volume":"268","author":"Taylor","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2008.02.002_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00011-005-1350-0","article-title":"Central administration of perfluorooctanoic acid inhibits cutaneous inflammation","volume":"54","author":"Taylor","year":"2005","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jpain.2008.02.002_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1015500531113","article-title":"Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia","volume":"26","author":"Yang","year":"2002","journal-title":"Inflammation"},{"key":"10.1016\/j.jpain.2008.02.002_bib38","doi-asserted-by":"crossref","first-page":"29275","DOI":"10.1155\/2007\/29275","article-title":"RAR\/RXR and PPAR-\/RXR signaling in spinal cord injury","volume":"2007","author":"van Neerven","year":"2007","journal-title":"PPAR Res"},{"key":"10.1016\/j.jpain.2008.02.002_bib39","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/j.1460-9568.2006.05037.x","article-title":"Altered PPAR-gamma expression and activation after transient focal ischemia in rats","volume":"24","author":"Victor","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jpain.2008.02.002_bib40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000087655","article-title":"Central proinflammatory cytokines and pain enhancement","volume":"14","author":"Wieseler-Frank","year":"2005","journal-title":"Neurosignals"},{"key":"10.1016\/j.jpain.2008.02.002_bib41","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1074\/jbc.275.3.1873","article-title":"A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation","volume":"275","author":"Mikami","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpain.2008.02.002_bib42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0079-6123(00)29033-X","article-title":"Pain following spinal cord injury: Pathophysiology and central mechanisms","volume":"129","author":"Yezierski","year":"2000","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.jpain.2008.02.002_bib43","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.neuroscience.2006.05.021","article-title":"Regulation of retinoic acid receptors alpha, beta and retinoid X receptor alpha after sciatic nerve injury","volume":"141","author":"Zhelyaznik","year":"2006","journal-title":"Neuroscience"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590008004173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590008004173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:46:04Z","timestamp":1761507964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590008004173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1526590008004173"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2008.02.002","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrathecal Rosiglitazone Acts at Peroxisome Proliferator\u2013Activated Receptor-\u03b3 to Rapidly Inhibit Neuropathic Pain in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2008.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}